HAVANA TIMES, Sept. 24 — Heberprot-P, created by specialists from the Genetic Engineering and Biotechnology Centre (CIGB) and the National Institute of Angiology and Vascular Surgery, has benefited more than 16,000 diabetic patients in Cuba, Miriela Gil Mena, coordinator of the Programme for the National Extension of that medicine which reduces the chances of an amputation, said. There are around 285 million diabetic persons in the world, reported IPS.
“The Supreme Court has chosen to endorse the aspirations of a man guilty of corruption,…
The "migrant dream" of Cubans is under the scrutiny of researchers from the University of…
Today’s featured band is Monsieur Periné from Colombia with the song “Mi Libertad” from their…
In order to improve navigation and features, Havana Times uses cookies.